Literature DB >> 19025426

Comparison of opioid requirements and analgesic response in opioid-tolerant versus opioid-naïve patients after total knee arthroplasty.

Asad E Patanwala1, Donna L Jarzyna, Michael D Miller, Brian L Erstad.   

Abstract

STUDY
OBJECTIVES: To compare opioid requirements in opioid-tolerant and opioid-naïve patients after total knee arthroplasty, and to compare pain scores, sedation scores, and adverse effects between the groups.
DESIGN: Prospective, observational study.
SETTING: Academic medical center. PATIENTS: Twenty-nine patients aged 18 years or older who underwent elective total knee arthroplasty between October 1, 2005, and June 31, 2007.
MEASUREMENTS AND MAIN RESULTS: Patients were classified on the basis of their daily opioid consumption during the week before surgery: those who required 10 mg or less of oral morphine equivalent were considered opioid naïve (20 patients), and those who required at least 30 mg of oral morphine equivalent were opioid tolerant (nine patients). Postoperative opioid consumption, pain scores, sedation scores, and adverse effects were compared between the two groups up to 48 hours after discharge from the postanesthesia care unit (PACU). Postoperative opioid consumption (in intravenous morphine equivalents) was significantly greater in the opioid-tolerant group than in the opioid-naïve group in the PACU (median 56 vs 8.2 mg, p=0.0013), during the first 24 hours after discharge from the PACU (108 vs 20.5 mg, p=0.0004), and 24-48 hours after discharge from the PACU (152.3 vs 25 mg, p=0.0001). Pain scores, assessed by using a verbal numeric scale from 0-10, were significantly greater in the opioid-tolerant group than in the opioid-naïve group during the first 24 hours after discharge from the PACU (5.9 vs 4.1, p=0.03). We observed no significant difference in pain scores during the other time periods studied. Sedation scores and adverse effects were similar between groups.
CONCLUSION: After total knee arthroplasty, patients tolerant to opioids required significantly more opioids in the PACU and up to 48 hours after discharge from the PACU than did opioid-naïve patients. Opioid-tolerant patients also experienced greater pain during the first 24 hours after discharge from the PACU; however, sedation scores and adverse effects did not appear to be significantly different at any of the time periods studied. Clinicians need to be aggressive with pain management immediately after surgery and ensure that patients restart any opioid treatment at home as soon as possible.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19025426     DOI: 10.1592/phco.28.12.1453

Source DB:  PubMed          Journal:  Pharmacotherapy        ISSN: 0277-0008            Impact factor:   4.705


  18 in total

1.  Impact of Preoperative Opioid Use on Total Knee Arthroplasty Outcomes.

Authors:  Savannah R Smith; Jennifer Bido; Jamie E Collins; Heidi Yang; Jeffrey N Katz; Elena Losina
Journal:  J Bone Joint Surg Am       Date:  2017-05-17       Impact factor: 5.284

Review 2.  Reducing the burden of postoperative ileus: evaluating and implementing an evidence-based strategy.

Authors:  Jeffrey F Barletta; Anthony J Senagore
Journal:  World J Surg       Date:  2014-08       Impact factor: 3.352

3.  5-hydroxytryptamine type 3 receptor modulates opioid-induced hyperalgesia and tolerance in mice.

Authors:  De-Yong Liang; XiangQi Li; J David Clark
Journal:  Anesthesiology       Date:  2011-05       Impact factor: 7.892

4.  Use of OROS® hydromorphone in the treatment of osteoarthritis and osteoporosis: A pooled analysis of three non-interventional studies focusing on different starting doses.

Authors:  Johann D Ringe; Susanne Schäfer; Antonie M Wimmer; Thorsten Giesecke
Journal:  Wien Klin Wochenschr       Date:  2011-11-04       Impact factor: 1.704

5.  The associations between OPRM 1 and COMT genotypes and postoperative pain, opioid use, and opioid-induced sedation.

Authors:  Richard A Henker; Allison Lewis; Feng Dai; William R Lariviere; Li Meng; Gary S Gruen; Susan M Sereika; Hans Pape; Ivan S Tarkin; Indira Gowda; Yvette P Conley
Journal:  Biol Res Nurs       Date:  2012-06-20       Impact factor: 2.522

6.  Preprotachykinin-A gene disruption attenuates nociceptive sensitivity after opioid administration and incision by peripheral and spinal mechanisms in mice.

Authors:  Peyman Sahbaie; Xiaoyou Shi; Xiangqi Li; Deyong Liang; Tian-Zhi Guo; Yanli Qiao; David C Yeomans; Wade S Kingery; J David Clark
Journal:  J Pain       Date:  2012-10       Impact factor: 5.820

7.  Utilization and effectiveness of multimodal discharge analgesia for postoperative pain management.

Authors:  Karishma Desai; Ian Carroll; Steven M Asch; Tina Seto; Kathryn M McDonald; Catherine Curtin; Tina Hernandez-Boussard
Journal:  J Surg Res       Date:  2018-04-11       Impact factor: 2.192

8.  Cost-effectiveness of nonsteroidal anti-inflammatory drugs and opioids in the treatment of knee osteoarthritis in older patients with multiple comorbidities.

Authors:  J N Katz; S R Smith; J E Collins; D H Solomon; J M Jordan; D J Hunter; L G Suter; E Yelin; A D Paltiel; E Losina
Journal:  Osteoarthritis Cartilage       Date:  2015-10-23       Impact factor: 6.576

9.  Cost-Effectiveness of Tramadol and Oxycodone in the Treatment of Knee Osteoarthritis.

Authors:  Savannah R Smith; Jeffrey N Katz; Jamie E Collins; Daniel H Solomon; Joanne M Jordan; Lisa G Suter; Edward H Yelin; A David Paltiel; Elena Losina
Journal:  Arthritis Care Res (Hoboken)       Date:  2016-12-31       Impact factor: 4.794

10.  Opioids enhance CXCL1 expression and function after incision in mice.

Authors:  Yuan Sun; Peyman Sahbaie; DeYong Liang; Wenwu Li; J David Clark
Journal:  J Pain       Date:  2014-06-02       Impact factor: 5.820

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.